| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.036 | 0.5 |